Feb 14 (Reuters)-
Shin Nippon Biomedical Laboratories Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2016 Dec 31, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 11.55 10.42 16.50
(+10.8 pct) (-17.4 pct) (+11.9 pct)
Operating loss 2.10 loss 3.27 loss 2.25
Recurring loss 1.83 loss 3.89 loss 2.78
Net loss 1.78 2.68 loss 2.92
EPS loss 43.33 yen 67.47 yen loss 70.72 yen
Ann Div NIL
-Q2 div NIL NIL
-Q4 div NIL
NOTE - Shin Nippon Biomedical Laboratories Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T
((Tokyo Headline News Desk +813 6441 1812))